Background. Using the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute and American total mortality rates, the authors calculated the probability at birth of having a diagnosis of prostate cancer within a man's life to be 8.8% and then subtracted the incidence of
Inaccuracies in assignment of clinical stage for localized prostate cancer
β Scribed by Adam C. Reese; Natalia Sadetsky; Peter R. Carroll; Matthew R. Cooperberg
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 156 KB
- Volume
- 117
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: A clinical staging system based on the prostate-specific antigen (psa) and the calculated prostate carcinoma volume (cvca) construct previously has been proposed. this study was performed to assess whether this proposed clinical staging system was valid in an independent surgical and
## Abstract ## BACKGROUND. Early detection of smallβvolume prostate cancer (PCa) has led to the concept of focal therapy to treat PCa as an organβsparing, minimally invasive procedure. The authors sought to determine the frequency of unilateral cancers in the contemporary prostateβspecific antigen